Kestra Advisory Services’s Amylyx Pharmaceuticals AMLX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-12,936	Closed	-$478K	–	2055
2022 Q4	$478K	Sell	12,936 -29,747	-70%	-$1.1M	﹤0.01%	1437
2022 Q3	$1.2M	Buy	+42,683	New	+$1.2M	0.01%	887